<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Proliferating cell nuclear antigen (PCNA) expression was assessed in oesophageal epithelium from 70 patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>PCNA counts were expressed in the form of a PCNA index </plain></SENT>
<SENT sid="2" pm="."><plain>There were 24 patients with dysplastic epithelium, nine with regenerative atypia, 18 with benign histology and 19 with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> arising in Barrett's epithelium </plain></SENT>
<SENT sid="3" pm="."><plain>The PCNA index of malignant tissue was significantly different from that of benign (P &lt; 0.001) and dysplastic (P &lt; 0.05) specimens </plain></SENT>
<SENT sid="4" pm="."><plain>PCNA indices in histologically <z:mpath ids='MPATH_458'>normal</z:mpath> Barrett's epithelium adjacent to a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> were significantly different (P &lt; 0.001) from those in <z:mpath ids='MPATH_458'>normal</z:mpath> Barrett's epithelium with no adjacent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These findings support the use of PCNA measurement in the assessment of Barrett's epithelium </plain></SENT>
</text></document>